Vytisknout
0546459 - FGÚ 2022 RIV CH eng J - Článek v odborném periodiku
Mareš, Pavel - Kozlová, Lucie - Mikulecká, Anna - Kubová, Hana
The GluN2B-Selective Antagonist Ro 25-6981 Is Effective against PTZ-Induced Seizures and Safe for Further Development in Infantile Rats.
Pharmaceutics. Roč. 13, č. 9 (2021), č. článku 1482. E-ISSN 1999-4923
Grant CEP: GA ČR(CZ) GA19-11931S; GA MZd(CZ) EF16_025/0007444
GRANT EU: European Commission(XE) 777554 - ID-EPTRI
Institucionální podpora: RVO:67985823
Klíčová slova: development * GluN2B-selective antagonist * Ro 25-6981 * anti-seizure effects * motor performance * memory * immature rats
Obor OECD: Developmental biology
Impakt faktor: 6.525, rok: 2021
Způsob publikování: Open access
https://www.mdpi.com/1999-4923/13/9/1482
Trvalý link: http://hdl.handle.net/11104/0322961
Mareš, Pavel - Kozlová, Lucie - Mikulecká, Anna - Kubová, Hana
The GluN2B-Selective Antagonist Ro 25-6981 Is Effective against PTZ-Induced Seizures and Safe for Further Development in Infantile Rats.
Pharmaceutics. Roč. 13, č. 9 (2021), č. článku 1482. E-ISSN 1999-4923
Grant CEP: GA ČR(CZ) GA19-11931S; GA MZd(CZ) EF16_025/0007444
GRANT EU: European Commission(XE) 777554 - ID-EPTRI
Institucionální podpora: RVO:67985823
Klíčová slova: development * GluN2B-selective antagonist * Ro 25-6981 * anti-seizure effects * motor performance * memory * immature rats
Obor OECD: Developmental biology
Impakt faktor: 6.525, rok: 2021
Způsob publikování: Open access
https://www.mdpi.com/1999-4923/13/9/1482
Trvalý link: http://hdl.handle.net/11104/0322961